17 September 2019
Dallas, TX, USA – Exercising several times a week may delay brain deterioration in people at high risk for Alzheimer’s disease, according to a study that scientists say merits further research to establish whether fitness can affect the progression of dementia. Research from UT Southwestern found that people who had accumulation of amyloid beta in the brain – a hallmark of Alzheimer’s disease – experienced slower degeneration in a region of the brain crucial for memory if they exercised regularly for one year.
Although exercise did not prevent the eventual spread of toxic amyloid plaques blamed for killing neurons in the brains of dementia patients, the findings suggest an intriguing possibility that aerobic workouts can at least slow down the effects of the disease if intervention occurs in the early stages.
“What are you supposed to do if you have amyloid clumping together in the brain? Right now doctors can’t prescribe anything,” said Dr. Rong Zhang (pictured), who led the clinical trial that included 70 participants ages 55 and older. “If these findings can be replicated in a larger trial, then maybe one day doctors will be telling high-risk patients to start an exercise plan. In fact, there’s no harm in doing so now.”
Reduced brain atrophy
The study published in the Journal of Alzheimer’s Disease compared cognitive function and brain volume between two groups of sedentary older adults with memory issues: One group did aerobic exercise (at least a half-hour workout four to five times weekly), and another group did only flexibility training.
Both groups maintained similar cognitive abilities during the trial in areas such as memory and problem solving. But brain imaging showed that people from the exercise group who had amyloid buildup experienced slightly less volume reduction in their hippocampus – a memory-related brain region that progressively deteriorates as dementia takes hold.
“It’s interesting that the brains of participants with amyloid responded more to the aerobic exercise than the others,” said Dr. Zhang, who conducted the trial at the Institute for Exercise and Environmental Medicine. “Although the interventions didn’t stop the hippocampus from getting smaller, even slowing down the rate of atrophy through exercise could be an exciting revelation.”
However, Dr. Zhang notes that more research is needed to determine how or if the reduced atrophy rate benefits cognition.
The search for dementia therapies is becoming increasingly pressing: More than 5 million Americans have Alzheimer’s disease, and the number is expected to triple by 2050.
Recent research has helped scientists gain a greater understanding of the molecular genesis of the disease, including a UT Southwestern discovery published last year that is guiding efforts to detect the condition before symptoms arise. Yet the billions of dollars spent on trying to prevent or slow dementia have yielded no proven treatments that would make an early diagnosis actionable for patients.
Fitness and brain health
Dr. Zhang is among a group of scientists across the world trying to determine if exercise may be the first such therapy.
His latest research builds upon numerous studies suggesting links between fitness and brain health. For example, a 2018 study showed that people with lower fitness levels experienced faster deterioration of vital nerve fibers in the brain called white matter. Research in mice has similarly shown exercise correlated with slower deterioration of the hippocampus – findings that prompted Dr. Zhang to investigate whether the same effects could be found in people.
“I’m excited about the results, but only to a certain degree,” Dr. Zhang said. “This is a proof-of-concept study, and we can’t yet draw definitive conclusions.”
Dr. Zhang is leading a five-year national clinical trial that aims to dig deeper into potential correlations between exercise and dementia. The trial, which includes six medical centers across the country, involves more than 600 older adults (ages 60-85) at high risk of developing Alzheimer’s disease. The study will measure whether aerobic exercise and taking specific medications to reduce high blood pressure and cholesterol can help preserve brain volume and cognitive abilities.
“Understanding the molecular basis for Alzheimer’s disease is important,” Dr. Zhang said. “But the burning question in my field is, ‘Can we translate our growing knowledge of molecular biology into an effective treatment?’ We need to keep looking for answers.”
Caption: Dr. Rong Zhang (left) of UT Southwestern reviews data at the Institute for Exercise and Environmental Medicine; a new study conducted at the IEEM shows regular exercise may slow down brain deterioration in people at high risk for Alzheimer’s disease (credit: Mei-Chun Jau).
NOTES FOR EDITORS
Full study: "Exercise Training in Amnestic Mild Cognitive Impairment: A One-Year Randomized Controlled Trial" (2019) T Tarumi, H Rossetti, BP Thomas, T Harris, BY Tseng, M Turner, C Wang, Z German, K Martin-Cook, AM Stowe, KB Womack, D Mathews, DR Kerwin, L Hynan, R Diaz-Arrastia, H Lu, C Munro Cullum, R Zhang, J Alzheimer Dis, published online in advance of Volume 71, Issue 2. The full study is available at: https://content.iospress.com/articles/journal-of-alzheimers-disease/jad181175.
The study was supported by the National Institutes of Health. It included collaborations with staff at the Institute for Exercise and Environmental Medicine (IEEM), a partnership between UT Southwestern and Texas Health Presbyterian Hospital Dallas. Dr. Zhang is Director of the Cerebrovascular Laboratory at the IEEM and is a Professor of Neurology & Neurotherapeutics and Internal Medicine at UT Southwestern’s Peter O’Donnell Jr. Brain Institute.
James Beltran, UT Southwestern Medical Center (+1 214-648-3404 or James.Beltran@utsouthwestern.edu).
About UT Southwestern Medical Center
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty has received six Nobel Prizes, and includes 22 members of the National Academy of Sciences, 17 members of the National Academy of Medicine, and 15 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,500 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in about 80 specialties to more than 105,000 hospitalized patients, nearly 370,000 emergency room cases, and oversee approximately 3 million outpatient visits a year.
About the Journal of Alzheimer's Disease
Now in its 22nd year of publication, the Journal of Alzheimer's Disease (JAD) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment, and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. Groundbreaking research that has appeared in the journal includes novel therapeutic targets, mechanisms of disease, and clinical trial outcomes. JAD has a 2018 Journal Impact Factor of 3.517 according to Journal Citation Reports (Web of Science Group, 2019). JAD is published by IOS Press. j-alz.com